This inventor holds 1 USPTO granted patent. Top assignee: Nagase Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Miyako Kakuma: Innovator in Hyperlipemia Treatment
Introduction
Miyako Kakuma is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of medical science, particularly in the treatment of hyperlipemia. Her innovative approach has the potential to impact the health of many individuals suffering from related diseases.
Latest Patents
Kakuma holds a patent for a method aimed at inhibiting hyperlipemia using emmeisou or an extract thereof. The patent, titled "Method for inhibiting hyperlipemia with emmeisou or an extract thereof," outlines a process that involves administering emmeisou or its extract to a subject. This method addresses hyperlipemia, which is linked to various diseases, including arteriosclerosis.
Career Highlights
Miyako Kakuma is associated with Nagase Co., Ltd., where she continues to develop her research and innovations. Her work has garnered attention for its potential applications in medical treatments and health improvement.
Collaborations
Kakuma has collaborated with esteemed colleagues, including Toshitsugu Miyazaki and Kunio Kosaka. These partnerships have contributed to her research and the advancement of her patented methods.
Conclusion
Miyako Kakuma's contributions to the field of hyperlipemia treatment highlight her innovative spirit and dedication to improving health outcomes. Her work exemplifies the impact of research and invention in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
